Chemotherapy options in castration-resistant prostate cancer
Conclusions: Chemotherapy remains an essential component of CRPC therapy, and biomarkers are being identified to define clinical scenarios where chemotherapy may be the optimal therapy choice.
Source: Indian Journal of Urology - Category: Urology & Nephrology Authors: Benjamin A Teply Ralph J Hauke Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Docetaxel | Hormonal Therapy | Hormones | Prostate Cancer | Taxotere | Urology & Nephrology